---
schema_version: "secwatch.filing_event.v1"
accession: "0000947871-26-000546"
form_type: "8-K"
ticker: "EMBC"
cik: "0001872789"
company_name: "Embecta Corp."
filed_at: "2026-05-15T13:15:29+00:00"
generated_at: "2026-05-15T13:16:09.935768+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Embecta completes acquisition of Owen Mumford for £100M upfront plus up to £50M earnout

## Summary
- Acquisition completed May 15, 2026; Owen Mumford is a UK-based medical device and drug-delivery technology manufacturer.
- Upfront cash payment of £100M at closing; up to £50M additional based on Aidaptus auto-injector sales through June 2029.
- Strategic move to transform embecta into a broad-based medical supplies company serving obesity, diabetes, autoimmune, and anaphylaxis markets.
- Adds differentiated drug-delivery platform with Aidaptus next-generation auto-injector and strong IP portfolio.
- Combines Owen Mumford's device design, molding, and assembly with embecta's global commercial infrastructure and manufacturing scale.

## SEC filing metadata
- accession: 0000947871-26-000546
- form_type: 8-K
- ticker: EMBC
- cik: 0001872789
- company_name: Embecta Corp.
- filed_at: 2026-05-15T13:15:29+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1872789/000094787126000546/0000947871-26-000546-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1872789/000094787126000546/ss6329586_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000947871-26-000546
- JSON: https://secwatch.observer/filing/0000947871-26-000546.json
- Plain text: https://secwatch.observer/filing/0000947871-26-000546.txt

## Key facts
- M&A Transactions
  Embecta Corp. completed an acquisition involving Owen Mumford Holdings Limited for £100 million upfront cash plus up to £50 million milestone payments (closed 2026-05-15).
  - Action: acquisition
  - Counterparty: Owen Mumford Holdings Limited
  - Consideration: £100 million upfront cash plus up to £50 million milestone payments
  - Closing: 2026-05-15
  source text: Ellen Owen, Kim Priddis and Nancy Millington. Pursuant to the terms and conditions of the Purchase Agreement, embecta acquired Owen Mumford for an upfront cash payment of £100 million at closing (subject to customary adjustments, including for closing net cash) and will pay up to an additional £50 million upon the achievement of certain commercial milestones
  evidence_url: https://www.sec.gov/Archives/edgar/data/1872789/000094787126000546/0000947871-26-000546-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.